The cost for each drug can easily exceed $1000 per month
Appetite regulation often becomes more predictable, and early nausea may decrease or resolve
A simple strategy: at every meal, eat your protein source first, before anything else
Low sodium causes fatigue, headaches, and dizziness
Liquid options (protein shakes with fruit) are often better tolerated than solid food when appetite is suppressed
Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes